Literature DB >> 18576326

Is CCR2 the right chemokine receptor to target in rheumatoid arthritis?

Amanda E I Proudfoot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18576326     DOI： 10.1002/art.23590

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

Review 1.  Pharmacological modulation of chemokine receptor function.

Authors:  D J Scholten; M Canals; D Maussang; L Roumen; M J Smit; M Wijtmans; C de Graaf; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 3.  Targeting cells in motion: migrating toward improved therapies.

Authors:  Jason W Griffith; Andrew D Luster
Journal:  Eur J Immunol       Date:  2013-05-13       Impact factor: 5.532

4.  Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Authors:  Graeme O'Boyle; Paul Mellor; John A Kirby; Simi Ali
Journal:  FASEB J       Date:  2009-08-10       Impact factor: 5.191

5.  Lymph node stromal CCL2 limits antibody responses.

Authors:  Dragos C Dasoveanu; Hyeung Ju Park; Catherine L Ly; William D Shipman; Susan Chyou; Varsha Kumar; David Tarlinton; Burkhard Ludewig; Babak J Mehrara; Theresa T Lu
Journal:  Sci Immunol       Date:  2020-03-20

6.  Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.

Authors:  Maria C Lebre; Clarissa E Vergunst; Ivy Y K Choi; Saïda Aarrass; Ana S F Oliveira; Tim Wyant; Richard Horuk; Kris A Reedquist; Paul P Tak
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

7.  In silico Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

8.  CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis.

Authors:  Yuanfan Wang; Long Cui; Waldemar Gonsiorek; Soo-Hong Min; Gopinadhan Anilkumar; Stuart Rosenblum; Joseph Kozlowski; Daniel Lundell; Jay S Fine; Ethan P Grant
Journal:  J Inflamm (Lond)       Date:  2009-11-11       Impact factor: 4.981

Review 9.  Garden of therapeutic delights: new targets in rheumatic diseases.

Authors:  Jean M Waldburger; Gary S Firestein
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.